Table 1.
No. | Putative Identification a | RT b (min) | UHPLC-LTQXL-IT-MS/MS | p-Value | Id g | ||||
---|---|---|---|---|---|---|---|---|---|
m/z Posi c | m/z Nega d | M.W. e | MSn Fragment Pattern f | UV (nm) | |||||
1 | Quinic acid | 1.02 | - | 191 | 192 | 173 | 214, 279 | 9.00E-04 | Ref. [33] |
2 | Gallic acid | 1.37 | - | 169 | 170 | - | 226, 272 | 3.00E-04 | STD |
3 | 6-Hydroxykaempferol-O-galloylhexoside | 7.09 | 617 | 615 | 616 | 463 > 301 | 221, 265, 352 | 2.00E-04 | Ref. [32] |
4 | Quercetin-3-O-arabinoside | 7.89 | 435 | 433 | 434 | 301 | 239, 368 | 8.00E-06 | Ref. [35] |
5 | Quercetin-3-O-rhamnoside | 8.08 | 449 | 447 | 448 | 301 > 151 | 232, 277 | 4.00E-06 | Ref. [35] |
6 | Dicaffeoylquinic acid | 8.28 | 517 | 515 | 516 | 353 > 191 | 214, 322 | 4.90E-03 | Ref. [33] |
7 | Kaempferol-3-O-rhamnoside | 8.61 | 433 | 431 | 432 | 285 | 228, 280 | 3.40E-03 | Ref. [35] |
8 | Kaempferol derivatives | 8.63 | 479 | 477 | 478 | 431 > 285 | 271, 281 | 4.60E-03 | Ref. [35] |
9 | Catechin | 8.72 | 291 | 289 | 290 | 245 | 213, 303 | 2.90E-03 | Ref. [36] |
10 | Isorhamnetin | 8.74 | 317 | 315 | 316 | 300 | 366 | 4.00E-04 | Ref. [32] |
11 | Digalloyl-hexoside | 8.8 | 485 | 483 | 484 | 169 | 276 | 2.29E-02 | Ref. [34] |
12 | N.I. 1 | 8.96 | 601 | 599 | 600 | 301 > 151 | 214, 268 | 1.60E-03 | |
13 | Kaempferol-7-O-rutinoside | 9.34 | 595 | 593 | 594 | 447 > 285 | 276 | 2.00E-09 | Ref. [33] |
14 | Quercetin | 9.69 | 303 | 301 | 302 | 151 | 214, 274 | 7.00E-04 | STD |
15 | Genistein | 10.47 | 271 | 269 | 270 | 253, 243, 215, 153 | 285, 318 | 3.70E-03 | STD |
16 | Patuletin | 10.59 | 333 | 331 | 332 | 287 | 269, 316 | 8.40E-03 | Ref. [32] |
17 | Kaempferol | 10.63 | 287 | 285 | 286 | - | 279 | 4.21E-02 | STD |
18 | N.I. 2 | 10.77 | 229 | 227 | 228 | 165 > 111 | 202, 280 | 7.00E-04 | |
19 | N.I. 3 | 10.88 | 329 | 327 | 328 | 197, 291 | 202, 279 | 3.00E-04 | |
20 | N.I. 4 | 11.95 | 309 | 307 | 308 | 289 > 271 | 206, 282, 314 | 1.57E-02 | |
21 | N.I. 5 | 12.97 | 313 | 311 | 312 | 293 > 275 | 218, 366 | 1.35E-02 | |
22 | N.I. 6 | 13.78 | 315 | 313 | 314 | 201 | 221, 279 | 5.00E-04 | |
23 | N.I. 7 | 14.53 | 529 | 527 | 528 | 277 > 233 | 226, 280 | 7.00E-04 | |
24 | N.I. 8 | 14.57 | 295 | 293 | 294 | 275, 195 | 226, 280 | 3.80E-03 |
a Putative metabolites based on variable importance projection (VIP) analysis with cutoff value of 0.7 and a p-value <0.05. b Retention time. c Molecular ion detected in positive mode, [M + H]+. d Molecular ion detected in negative mode, [M − H]−. e Molecular weight. f MSn fragment patterns detected in negative ion mode. g Identification: STD, standard compound/Ref., references.